Please use this identifier to cite or link to this item:
Title: Clinical and neurocognitive predictors of functional outcome in depressed patients with partial response to treatment: one year follow-up study
Author: Castellano, Sabrina
Torrent, Carla
Petralia, M.Cristina
Godos, Justyna
Cantarella, Rita A.
Ventimiglia, Andrea
Vivo, Simona de
Platania, Silvia
Guarnera, Maria
Pirrone, Concetta
Drago, Filippo
Vieta i Pascual, Eduard, 1963-
Nuovo, Santo Di
Popovic, Dina
Caraci, Filippo
Keywords: Depressió psíquica
Trastorns de la cognició
Mental depression
Cognition disorders
Issue Date: 28-Feb-2020
Publisher: Dove Medical Press
Abstract: Background: Cognitive dysfunction represents a distinct biological and clinical dimension in major depression disorders (MDD) and cognitive performance strongly affects psychosocial functioning in patients diagnosed with MDD. Objective: To assess which neurocognitive variables at baseline predict the functional outcome of MDD patients in a 1-year follow-up study as assessed by Functioning Assessment Short Test (FAST) and whether the improvement observed on affective and cognitive symptoms in our 12 week-prospective observational study after treatment with selective serotonin reuptake inhibitors (SSRIs) and selective noradrenalin reuptake inhibitors (SNRIs) can affect the following long-term psychosocial functional outcome at 1 year in the same MDD patients. Methods: We recruited a total of 31 patients (8 males; 23 females) with MDD who had previously completed a pharmacological treatment with SSRIs (n = 22) or SNRIs (n = 9) for 12 weeks, and then continued the same pharmacological treatment for 1 year. After an average 1-year follow-up, they were interviewed with the FAST to assess functional outcome. Multivariate analyses were applied to identify clinical and neurocognitive predictors of functional outcome. Results: Total Montreal Cognitive Assessment (MoCA), Digit Span forward (Span F) and backward (Span B), and 15 Rey words immediate recall (Rey I) scores significantly correlated with FAST. However, after performing regression models only Rey immediate recall score was useful to predict long-term functional outcome (Pearson correlation coefficient R= -0.68, p < 0.001) in four specific subdomains of FAST. When considering changes in affective and cognitive symptoms at the end of the 12 weeks of pharmacological treatment with SSRI or SNRIs (T1-T0) by multiple regression analysis, we found that Span F-test predicted scores in the FAST leisure domain, whereas, changes in Span F, Frontal Assessment Battery (FAB) and Rey I predicted psychosocial functioning in the specific 'cognitive' subdomains of FAST. Conclusion: Our data suggest that long-term psychosocial functioning can be influenced by neurocognitive performance at baseline, with verbal memory playing a key role in overall functioning. Furthermore, improvement in verbal memory can predict functional outcome at one year in MDD patients with a recent history of partial response to antidepressants.
Note: Reproducció del document publicat a:
It is part of: Neuropsychiatric Disease and Treatment, 2020, vol. 16, p. 589-595
Related resource:
ISSN: 1176-6328
Appears in Collections:Articles publicats en revistes (Medicina)
Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)

Files in This Item:
File Description SizeFormat 
700192.pdf1.21 MBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons